K. A. Ebrahimi, “Significance of KIT and PDGFRA mutations in gastric gastrointestinal stromal tumor imatinib-naive surgically treated patients”, Vojnosanit Pregl, vol. 76, no. 12, Jul. 2021, doi: 10.2298/VSP180205048E.